Coherus BioSciences, Inc. Quarterly Costs and Expenses in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Coherus BioSciences, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2020 to Q3 2024.
  • Coherus BioSciences, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $77.2M, a 27.6% decline year-over-year.
  • Coherus BioSciences, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $443M, a 11.5% increase year-over-year.
  • Coherus BioSciences, Inc. annual Costs and Expenses for 2023 was $460M, a 1.6% decline from 2022.
  • Coherus BioSciences, Inc. annual Costs and Expenses for 2022 was $468M, a 20.7% decline from 2021.
  • Coherus BioSciences, Inc. annual Costs and Expenses for 2021 was $590M, a 84.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $443M $77.2M -$29.4M -27.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $472M $85.5M -$7.77M -8.33% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $480M $120M +$19.4M +19.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $460M $160M +$63.6M +65.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 $397M $107M -$19.3M -15.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $416M $93.3M -$10.9M -10.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $427M $100M -$40.9M -29% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $468M $96.8M -$16.1M -14.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $484M $126M +$10.6M +9.18% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $473M $104M -$7.64M -6.84% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $481M $141M -$109M -43.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $590M $113M +$18.9M +20.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 $571M $115M +$35.5M +44.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $536M $112M +$41.4M +58.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $495M $250M +$175M +232% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $320M $94M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $79.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $70.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $75.3M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.